Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HT4Y
|
|||
| Drug Name |
CC-92480
|
|||
| Synonyms |
CELMoD
Click to Show/Hide
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Phase 1/2 | [1] | |
| Company |
Celgene Summit, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03374085) A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.